<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="57176">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02111733</url>
  </required_header>
  <id_info>
    <org_study_id>TnT-HD</org_study_id>
    <nct_id>NCT02111733</nct_id>
  </id_info>
  <brief_title>Is High Sensibility Troponins a Dialysable Marker in Hemodialysis Patients and Does it Have Prognostic Value?</brief_title>
  <acronym>TnT-HD</acronym>
  <official_title>Is High Sensibility Troponins a Dialysable Marker in Hemodialysis Patients and Does it Have Prognostic Value?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of High sensibility troponin levels modification by hemodialysis in terminal
      renal failure patient at Sherbrooke University Hospital Center as determined by serial
      measurements. Verification of potential effects of these levels and their variation as
      predictors of cardiovascular outcomes and events at 6 and 12 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recruiting of hemodialysis patients of the nephrology renal supplementation clinics at
      Sherbrooke University Hospital Center to measure three blood level of high-sensibility
      troponins before and after standard dialysis. Verification on the variation of these levels
      after dialysis. Follow-up at 6 and 12 months of the patient for Cardiovascular events and
      death and verification of a possible predictive value of troponin blood levels for these
      events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>High sensibility troponins T blood level variation</measure>
    <time_frame>1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>Verification of high sensibility troponins T blood after classical hemodialysis compared to pre-treatment levels.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prognostic value of high sensibility troponins T blood level variation</measure>
    <time_frame>at 6 and 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluation of a potential prognosis value of high sensibility troponins T blood levels and its variation after hemodialysis.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Renal Failure</condition>
  <arm_group>
    <arm_group_label>Hs-TnT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hs-TNT dosage</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hs-TNT dosage</intervention_name>
    <description>Bloodwork before and after hemodialysis for high sensibility troponins T blood level</description>
    <arm_group_label>Hs-TnT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  over 50 years, no symptoms, over 1 months of hemodialysis

        Exclusion Criteria:

          -  1 or more in the last month; Acute coronary syndrome, Heart failure decompensated,
             Myo or Pericarditis, Pulmonary embolism, Sepsis/shock, Stroke or transient ischemic
             attack, Malignant high blood pressure, Arrythmia, electrical cardio-version, major
             trauma, significant burnings (&gt;25%), Chemotherapy, Cardiovascular surgery,
             percutaneous angio-intervention,

          -  Chronic systemic disease (sarcoidosis, amyloidosis, LED, Etc.)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel Nguyen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Sherbrooke</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier universitaire de Sherbrooke</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 8, 2014</lastchanged_date>
  <firstreceived_date>December 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
